Lex Wunderink, MD, PhD
- 2Articles
- 8.5KReads
- 2007–2012Active
- 9Collaborators
- 35Citations
About
Lex Wunderink, MD, PhD, has published research focused on schizophrenia and schizoaffective disorders within the field of neurology. Contributions include studies on cannabis use in first-episode psychosis and comparisons of guided discontinuation versus maintenance treatment in remitted psychosis, examining relapse rates and functional outcomes. Wunderink's work, published between 2007 and 2012, frequently involved collaboration with Durk Wiersma and other co-authors.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
